Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease-Reference-Cited by-同舟云学术

Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease

Published:2015-08 Issue:33 Volume:94 Page:e1161
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Costa Leandro M.A.,Rezende Paulo C.,Garcia Rosa M.R.,Uchida Augusto H.,Seguro Luis Fernando B.C.,Scudeler Thiago L.,Bocchi Edimar A.,Krieger Jose E.,Hueb Whady,Ramires José Antonio F.,Filho Roberto Kalil

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference41 articles.

1. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts.;Santulli;J Cardiovasc Dis,2013

2. Myocardial ischemia-reperfusion injury: a neglected therapeutic target.;Hausenloy;J Clin Invest,2013

3. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.;Murry;Circulation,1986

4. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.;Deutsch;Circulation,1990

5. Preconditioning the human myocardium.;Yellon;Lancet,1993

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Dapagliflozin in Ischemic Preconditioning in Patients with Symptomatic Coronary Artery Disease—DAPA-IP Study Protocol;Pharmaceuticals;2024-07-10

2. Optimizing patient preparation prior to cardiac surgery;Kardiologiya i serdechno-sosudistaya khirurgiya;2023

3. Protective or Inhibitory Effect of Pharmacological Therapy on Cardiac Ischemic Preconditioning: A Literature Review;Current Vascular Pharmacology;2022-09

4. Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial;BMC Cardiovascular Disorders;2021-10-01

5. Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention;Medicine;2020-10-30